Literature DB >> 9581574

Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils.

F Mollinedo1, M Nakajima, A Llorens, E Barbosa, S Callejo, C Gajate, A Fabra.   

Abstract

The expression of cell-surface adhesion proteins and the release of extracellular-matrix degradative enzymes constitute crucial processes for the attachment of neutrophils to the endothelium and for the subsequent extravasation of these cells through the endothelial layer. We have analysed in resting human neutrophils the subcellular localization of heparanase, a heparan-sulphate-degrading endoglycosidase that can degrade basement-membrane components, thereby facilitating neutrophil passage into the tissue during an inflammatory reaction. By subcellular fractionation of postnuclear supernatants from resting human neutrophils on continuous sucrose gradients, we have found that heparanase activity was mainly located in gelatinase-containing tertiary granules. Using a specific antibody, the 96-kDa heparanase protein was further located in the gelatinase-rich subcellular fractions. Following immunoblotting and immunoprecipitation analysis in the distinct subcellular fractions, we also found co-localization of heparanase and Mo1 (CD11b/CD18), a leucocyte integrin involved in the attachment of neutrophils to the endothelium, in the fractions enriched in gelatinase-containing tertiary granules. Treatment of human neutrophils with tumour necrosis factor or granulocyte/macrophage colony-stimulating factor induced an increase in the CD11b/CD18 cell-surface expression, as well as the release of both gelatinase (matrix metalloproteinase-9) and heparanase, but not of other granule markers, indicating a major co-localization of gelatinase, heparanase and CD11b/CD18 in the same organelle. Furthermore, confocal laser scanning microscopy using specific antibodies against gelatinase and heparanase revealed a major co-localization of both enzymes in intracellular cytoplasmic granules. The major localization of heparanase and CD11b/CD18 in the gelatinase-containing tertiary granule supports the notion that mobilization of this organelle can regulate extravasation of human neutrophils.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9581574      PMCID: PMC1218875          DOI: 10.1042/bj3270917

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  55 in total

1.  Subcellular localization and release of human neutrophil gelatinase, confirming the existence of separate gelatinase-containing granules.

Authors:  L Kjeldsen; O W Bjerrum; J Askaa; N Borregaard
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

2.  Structure and expression of neutrophil gelatinase cDNA. Identity with type IV collagenase from HT1080 cells.

Authors:  P Devarajan; J J Johnston; S S Ginsberg; H E Van Wart; N Berliner
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

Review 3.  Human neutrophil granules and secretory vesicles.

Authors:  N Borregaard; K Lollike; L Kjeldsen; H Sengeløv; L Bastholm; M H Nielsen; D F Bainton
Journal:  Eur J Haematol       Date:  1993-10       Impact factor: 2.997

4.  Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase.

Authors:  L Kjeldsen; A H Johnsen; H Sengeløv; N Borregaard
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

5.  Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity.

Authors:  J Juarez; G Clayman; M Nakajima; K K Tanabe; H Saya; G L Nicolson; D Boyd
Journal:  Int J Cancer       Date:  1993-08-19       Impact factor: 7.396

6.  Characteristics of 92 kDa type IV collagenase/gelatinase produced by granulocytic leukemia cells: structure, expression of cDNA in E. coli and enzymic properties.

Authors:  T Pourmotabbed; T L Solomon; K A Hasty; C L Mainardi
Journal:  Biochim Biophys Acta       Date:  1994-01-11

7.  Structural and functional heterogeneity among peroxidase-negative granules in human neutrophils: identification of a distinct gelatinase-containing granule subset by combined immunocytochemistry and subcellular fractionation.

Authors:  L Kjeldsen; D F Bainton; H Sengeløv; N Borregaard
Journal:  Blood       Date:  1993-11-15       Impact factor: 22.113

8.  Localization of rap1 and rap2 proteins in the gelatinase-containing granules of human neutrophils.

Authors:  F Mollinedo; D Perez-Sala; C Gajate; B Jimenez; P Rodriguez; J C Lacal
Journal:  FEBS Lett       Date:  1993-07-12       Impact factor: 4.124

9.  Human neutrophil gelatinase is a collagenase type IV.

Authors:  F Morel; S Berthier; M Guillot; P Zaoui; C Massoubre; F Didier; P V Vignais
Journal:  Biochem Biophys Res Commun       Date:  1993-02-26       Impact factor: 3.575

10.  Subcellular localization and dynamics of Mac-1 (alpha m beta 2) in human neutrophils.

Authors:  H Sengeløv; L Kjeldsen; M S Diamond; T A Springer; N Borregaard
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

View more
  20 in total

Review 1.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

Authors:  I Vlodavsky; Y Friedmann
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.

Authors:  S L Leib; D Leppert; J Clements; M G Täuber
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Endothelium-derived GM-CSF influences expression of oncostatin M.

Authors:  Wafa M Elbjeirami; Elizabeth M Donnachie; Alan R Burns; C Wayne Smith
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-20       Impact factor: 4.249

Review 4.  Clinical correlates of common corneal neovascular diseases: a literature review.

Authors:  Nizar Saleh Abdelfattah; Mohamed Amgad; Amira A Zayed; Hamdy Salem; Ahmed E Elkhanany; Heba Hussein; Nawal Abd El-Baky
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

5.  A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells.

Authors:  J E De Larco; B R Wuertz; K A Rosner; S A Erickson; D E Gamache; J C Manivel; L T Furcht
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

6.  Tumor metastasis and the reciprocal regulation of heparanase gene expression by nuclear factor kappa B in human gastric carcinoma tissue.

Authors:  Hou-Jun Cao; Yong Fang; Xing Zhang; Wen-Jun Chen; Wen-Peng Zhou; Hong Wang; Lin-Bo Wang; Jin-Min Wu
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

Review 7.  Heparan sulfate proteoglycans and their binding proteins in embryo implantation and placentation.

Authors:  Catherine B Kirn-Safran; Sonia S D'Souza; Daniel D Carson
Journal:  Semin Cell Dev Biol       Date:  2007-07-31       Impact factor: 7.727

8.  Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation.

Authors:  A J Brown; M Alicknavitch; S S D'Souza; T Daikoku; C B Kirn-Safran; D Marchetti; D D Carson; M C Farach-Carson
Journal:  Bone       Date:  2008-06-06       Impact factor: 4.398

9.  Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: possibility of multiple levels of heparanase regulation.

Authors:  Olga Ostrovsky; Michael Korostishevsky; Itay Shafat; Margarita Mayorov; Neta Ilan; Israel Vlodavsky; Arnon Nagler
Journal:  J Leukoc Biol       Date:  2009-04-30       Impact factor: 4.962

10.  Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis.

Authors:  Orit Goldshmidt; Eyal Zcharia; Rinat Abramovitch; Shula Metzger; Helena Aingorn; Yael Friedmann; Volker Schirrmacher; Eduardo Mitrani; Israel Vlodavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.